|
EP3698720A1
|
|
Head- and arm-rest device for use in medical scanning
|
|
EP3447066A1
|
|
New ccl2 peptides for use in cancer therapy
|
|
US2017239337A1
|
|
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
|
|
US2017343545A1
|
|
Determining Antigen Recognition through Barcoding of MHC Multimers
|
|
WO2013167136A1
|
|
Improving adoptive cell therapy with interferon gamma
|
|
WO2013107459A2
|
|
Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
|
|
US2015152503A1
|
|
Micrornas for prediction of treatment efficacy and prognosis of cancer patients
|
|
US2015065946A1
|
|
Therapeutic applications of calcium electroporation to effectively induce tumor necrosis
|
|
WO2013060328A1
|
|
Ikb based immunotherapy
|
|
BR112014009526A2
|
|
pd-l1-based immunotherapy
|
|
EP2710148A2
|
|
Microrna biomarkers for prognosis of patients with pancreatic cancer
|
|
WO2012126477A1
|
|
Fastening device, related tools and methods
|
|
EP2655660A2
|
|
Microrna for diagnosis of pancreatic cancer
|
|
WO2012052543A1
|
|
A method for treating a tissue region with an electric field
|
|
EP2432412A2
|
|
Electroporation device with improved tip and electrode support
|
|
WO2010054660A1
|
|
Double cannula system for anaesthetic needle
|
|
AU2009291312A1
|
|
YKL-40 as a marker for gastrointestinal cancers
|
|
CA2737274A1
|
|
Ykl-40 as a marker for selection of treatment and monitoring of a disease
|
|
NZ588757A
|
|
Indoleamine 2, 3-dioxygenase based immunotherapy
|
